Alnylam Pharmaceuticals (ALNY) Prepaid Assets (2009 - 2026)

Alnylam Pharmaceuticals has reported Prepaid Assets for 18 years, with the latest figure at $242.1 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets rose 58.84% year-over-year to $242.1 million; the trailing twelve-month figure through Mar 2026 stood at $242.1 million (up 58.84% YoY), and the FY2025 full-year result was $281.9 million, up 141.01% from the prior year.
• Prepaid Assets for Q1 2026 stood at $242.1 million, down from $281.9 million in the prior quarter.
• The five-year high for Prepaid Assets was $281.9 million in Q4 2025, with the low at $115.1 million in Q1 2022.
• Historically, Prepaid Assets has averaged $157.8 million across 5 years, with a median of $145.5 million in 2023.
• The largest YoY upside for Prepaid Assets was 141.01% in 2025 against a maximum downside of 24.53% in 2025.
• Alnylam Pharmaceuticals' Prepaid Assets stood at $132.9 million in 2022, then fell by 4.92% to $126.4 million in 2023, then decreased by 7.45% to $117.0 million in 2024, then surged by 141.01% to $281.9 million in 2025, then retreated by 14.11% to $242.1 million in 2026.
• The last three Prepaid Assets figures came in at $242.1 million (Q1 2026), $281.9 million (Q4 2025), and $188.0 million (Q3 2025), per Business Quant data.